Helena Norberg

Associate professor in pharmacy, PhD, MSc clinical pharmacy

Programme coordinator for BSc and MSc in pharmacy

Educational qualifications: Recognised university teacher

0000-0002-6785-2895

Contact

helena.norberg@umu.se

+46 90 786 68 21

Works at

Associate professor at Department of Medical and Translational Biology Section: Group Maria Gustafsson

hus H, Johan Bures väg 12, Biologihuset Umeå universitet, 901 87 Umeå

My research focuses on optimization of drug treatment with focus on implementation of new therapies in clinical practice and how AI can support healthcare professionals. I am programme coordinator and teach within the pharmacy programs.

Faricimab versus bevacizumab for neovascular age-related macular degeneration: cost analysis based on real-world data from the Swedish Macula Registry

Acta Ophthalmologica

Abdalla, Souad; Westborg, Inger; Pulkki-Brännström, Anni-Maria; et al.

Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin

European Journal of Clinical Pharmacology, Springer Nature 2024, Vol. 80, (9) : 1363-1371

Norberg, Helena; Andersson, Therese; Håkansson, Erik; et al.

Self-reported medication adherence among older people admitted to hospital: a descriptive study

Drugs - real world outcomes, Springer Nature 2023, Vol. 10 : 23-29

Irshaidat, Shayma; Gustafsson, Maria; Norberg, Helena

Older individuals’ experiences of medication management and care after discharge from hospital: an interview study

Patient Preference and Adherence, Dove Medical Press Ltd 2023, Vol. 17 : 781-792

Norberg, Helena; Lindqvist, Marcia Håkansson; Gustafsson, Maria

Prevalence and treatment of diabetes and pre-diabetes in a real-world heart failure population: a single-centre cross-sectional study

Open heart, BMJ Publishing Group Ltd 2022, Vol. 9, (2)

Håkansson, Erik; Brunström, Mattias; Norberg, Helena; et al.

Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study

BMJ Open, BMJ Publishing Group Ltd 2022, Vol. 12, (9)

Jern, Iréne; Forsell, Sara; Norberg, Helena

Motives, frequency, predictors and outcomes of MRA discontinuation in a real-world heart failure population

Open heart, BMJ Publishing Group Ltd 2022, Vol. 9, (2)

Jonsson, Anna; Wessberg, Gustav; Norberg, Helena; et al.

Self-reported medication adherence and pharmacy refill adherence among persons with ischemic stroke: a cross-sectional study

European Journal of Clinical Pharmacology, Springer Science+Business Media B.V. 2022, Vol. 78 : 869-877

Norberg, Helena; Sjölander, Maria; Glader, Eva-Lotta; et al.

Eligibility of Dapagliflozin and Empagliflozin in a Real-World Heart Failure Population

Cardiovascular Therapeutics, Hindawi Publishing Corporation 2021, Vol. 2021

Håkansson, Erik; Norberg, Helena; Själander, Sara; et al.

Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function

PLOS ONE, Public Library of Science 2021, Vol. 16, (10)

Jonsson, Anna; Norberg, Helena; Valham, Fredrik; et al.

A systematic approach for introduction of novel treatments to a chronic patient group: sacubitril-valsartan as a case study

European Journal of Clinical Pharmacology, Springer 2021, Vol. 77 : 125-131

Norberg, Helena; Bergdahl, Ellinor; Hellström Ängerud, Karin; et al.

Comparison of creatinine-based methods for estimating glomerular filtration rate in patients with heart failure

ESC Heart Failure, John Wiley & Sons 2020, Vol. 7, (3) : 1150-1160

Jonsson, Anna; Viklund, Ida; Jonsson, Andreas; et al.

Bridging the gap between clinical trials and clinical practice: sacubitril-valsartan in heart failure as a model

Umeå University medical dissertations, 2096

Norberg, Helena

Ny metod för regional implementering av nya behandlingar vid kronisk sjukdom

Läkartidningen, Läkartidningen Förlag 2020, Vol. 117, (46-47) : 1518-1518

Norberg, Helena

Differences in medical treatment and clinical characteristics between men and women with heart failure: a single-centre multivariable analysis

European Journal of Clinical Pharmacology, Springer 2020, Vol. 76, (4) : 539-546

Norberg, Helena; Pranic, Veronica; Bergdahl, Ellinor; et al.

Clinical trial enrolment favours men: Fewer women meet eligibility criteria for trials of heart failure medication is discussed by Helena Norberg from Sweden

European Heart Journal, OXFORD UNIV PRESS 2019, Vol. 40, (14) : 1104-1105

Norberg, Helena

Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors

Cardiovascular Therapeutics, Vol. 2019

Norberg, Helena; Bergdahl, Ellinor; Lindmark, Krister

Obstacles to mineralocorticoid receptor antagonists in a community-based heart failure population

Cardiovascular therapeutics, John Wiley & Sons 2018, Vol. 36, (5)

Jonsson, Anna; Norberg, Helena; Bergdahl, Ellinor; et al.

Who enrols and graduates from web-based pharmacy education: experiences from Northern Sweden

Currents in pharmacy teaching and learning, Elsevier 2018, Vol. 10, (8) : 1004-1012

Mattsson, Sofia; Gustafsson, Maria; Svahn, Sofia; et al.

Eligibility of sacubitril–valsartan in a real-world heart failure population: a community-based single-centre study

ESC Heart Failure, John Wiley & Sons 2018, Vol. 5, (2) : 337-343

Norberg, Helena; Bergdahl, Ellinor; Lindmark, Krister

Motives, predictors, and outcomes of MRA discontinuation in a real-world heart failure population

Jonsson, Anna; Wessberg, Gustav; Norberg, Helena; et al.

View publications in DiVA

Research projects

15 January 2023 until 14 January 2025

Smart Personalized Medication Assistant – SMAP

My teaching focuses on individualization of drug treatment within courses in pharmacotherapy and clinical pharmacy. I also teach in scientific methods for drug evaluation.